Content about Rare diseases

May 23, 2010
Genzyme to correct manufacturing quality violations at Mass. plant

Biotech company Genzyme will pay $175 million to the federal government as part of an...

May 16, 2010
Teva: Lou Gehrig’s disease treatment trial did not meet endpoints

An investigational drug made by Teva Pharmaceutical Industries was not effective in patients with Lou...

March 23, 2010
FDA to have Genzyme plant inspected, reviewed

Genzyme Corp. will have to submit to inspections of one of its plants by the...

February 25, 2010
FDA approves Shire's Type 1 Gaucher disease

The Food and Drug Administration has approved a new drug for treating a rare genetic...

February 2, 2010
Auxilium receives FDA approval for Dupuytren’s contracture treatment

The Food and Drug Administration has approved a drug for treating a debilitating hand condition...